TIMP1 and anti-neutrophil cytoplasmic antibody-associated vasculitis: Suppressed serum TIMP-1 was also shown in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) treated with rituximab [22].